|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:Hallucinogen
|
|
gptkbp:bindingTarget
|
gptkb:5-HT1A_receptor
gptkb:sigma-1_receptor
5-HT2A receptor
|
|
gptkbp:boilingPoint
|
160 °C (at 0.5 mmHg)
|
|
gptkbp:CASNumber
|
61-50-7
|
|
gptkbp:category
|
gptkb:Hallucinogen
gptkb:alkaloid
gptkb:serotonin_receptor_agonist
|
|
gptkbp:chemicalFormula
|
C12H16N2
|
|
gptkbp:color
|
white to yellow crystalline solid
|
|
gptkbp:discoveredBy
|
gptkb:Richard_Helmuth_Fredrick_Manske
|
|
gptkbp:discoveredIn
|
1931
|
|
gptkbp:effect
|
mystical experiences
euphoria
visual hallucinations
5–30 minutes (inhaled)
2–6 hours (oral with MAOI)
altered perception of time
|
|
gptkbp:featuredIn
|
book 'DMT: The Spirit Molecule' by Rick Strassman
|
|
gptkbp:foundIn
|
gptkb:Ayahuasca
|
|
gptkbp:hasInChIKey
|
KXANITVJZQZKSG-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CN(C)CCc1c[nH]c2cccc(C1)2
|
|
gptkbp:IUPACName
|
2-(1H-indol-3-yl)-N,N-dimethylethanamine
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
Schedule 9 (Australia)
|
|
gptkbp:mainStreet
|
gptkb:DMT
the spirit molecule
|
|
gptkbp:meltingPoint
|
44–46 °C
|
|
gptkbp:metabolism
|
gptkb:monoamine_oxidase
|
|
gptkbp:molecularWeight
|
188.27 g/mol
|
|
gptkbp:naturalOccurrence
|
some animals
various plants
human body (trace amounts)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL39122
6089
CHEBI:4610
|
|
gptkbp:relatedTo
|
gptkb:5-MeO-DMT
gptkb:bufotenin
psilocybin
serotonin
|
|
gptkbp:routeOfAdministration
|
inhalation
intramuscular injection
oral (with MAOI)
|
|
gptkbp:solubility
|
slightly soluble in water
soluble in ethanol
soluble in chloroform
|
|
gptkbp:toxicity
|
low acute toxicity
|
|
gptkbp:UNII
|
WUB6018FEM
|
|
gptkbp:usedIn
|
spiritual practices
shamanic rituals
|
|
gptkbp:bfsParent
|
gptkb:DMT
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
N,N-Dimethyltryptamine
|